当前位置: 首页 >> 检索结果
共有 131036 条符合本次的查询结果, 用时 3.2327393 秒

1521. Is generative artificial intelligence capable of clinical reasoning?

作者: Adam Rodman.;Eric J Topol.
来源: Lancet. 2025年405卷10480期689页

1522. Nancy Brown: using advocacy to advance cardiovascular health.

作者: Chloe Wilson.
来源: Lancet. 2025年405卷10480期688页

1523. Anticoagulation for extended venous thromboembolism treatment: less is really more.

作者: Saskia Middeldorp.;Jenneke Leentjens.
来源: Lancet. 2025年405卷10480期676-677页

1524. Understanding the scale of critical illness in Africa and the need for universal access to emergency and critical care.

作者: Nazir I Lone.;John A Masterson.;Swagata Tripathy.
来源: Lancet. 2025年405卷10480期674-675页

1525. H5N1 avian influenza: technical solutions, political challenges.

作者: The Lancet.
来源: Lancet. 2025年405卷10480期671页

1526. Towards definitive evidence about anticoagulation for atrial fibrillation after intracranial haemorrhage.

作者: Rustam Al-Shahi Salman.;Ashkan Shoamanesh.
来源: Lancet. 2025年405卷10482期872-873页

1527. Breaking dependency: strengthening the global tuberculosis response in the face of USAID cuts.

作者: Alimuddin Zumla.;Suvanand Sahu.;Dorothy Yeboah-Manu.;Delia Goletti.;Peter S Nyasulu.;Sayoki Mfinanga.;Mary Shilalukey-Ngoma.;Francine Ntoumi.;Alfonso J Rodriguez-Morales.;Dean B Everett.;Adeeba Kamarulzaman.;David S Hui.
来源: Lancet. 2025年405卷10483期958-961页

1528. USAID programme suspension in Nigeria: a looming health crisis.

作者: Mubarak Jolayemi Mustapha.;Victor Ayooluwa Adeloye.;Fatihi Bamigbola Mustapha.;Kehinde Alare.
来源: Lancet. 2025年405卷10483期972页

1529. Unjustified silence in the face of this new war in eastern DR Congo.

作者: Marie Hatem.;Adélaïde Blavier.;Susanne Alldén.;Jennifer Foucart.;Bérangère Taxil.;Laura E Keyser.;Anne Weyembergh.;Olivier Vandenberg.; .
来源: Lancet. 2025年405卷10483期971页

1530. Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.

作者: Roland Veltkamp.;Eleni Korompoki.;Kirsten H Harvey.;Emily R Harvey.;Cornelia Fießler.;Uwe Malzahn.;Viktoria Rücker.;Joan Montaner.;Valeria Caso.;Igor Sibon.;Peter Ringleb.;Omid Halse.;Klemens Hügen.;Sabine Ullmann.;Carolin Schuhmann.;Gabriele Putz Todd.;Kirsten Haas.;Elena Palà.;Stéphanie Debette.;Morgane Lachaize.;Tim D'Aoust.;Christian Enzinger.;Stefan Ropele.;Simon Fandler-Höfler.;Melanie Haidegger.;Yanzhong Wang.;Hatem A Wafa.;Virginia Cancelloni.;Maria Giulia Mosconi.;Gregory Y H Lip.;Deirdre A Lane.;Walter E Haefeli.;Kathrin I Foerster.;Viktoria S Wurmbach.;Peter Brønnum Nielsen.;Karim Hajjar.;Patrick Müller.;Sven Poli.;Jan Purrucker.;Mona Laible.;Lucio D'Anna.;Yolanda Silva.;Reyes de Torres Chacon.;Patricia Martínez-Sánchez.;Marion Boulanger.;Bo Norrving.;Guillaume Paré.;Rolf Wachter.;George Ntaios.;Charles D A Wolfe.;Peter U Heuschmann.; .
来源: Lancet. 2025年405卷10482期927-936页
Direct oral anticoagulants (DOACs) reduce the rate of thromboembolism in patients with atrial fibrillation but the benefits and risks in survivors of intracerebral haemorrhage are uncertain. We aimed to determine whether DOACs reduce the risk of ischaemic stroke without substantially increasing the risk of recurrent intracerebral haemorrhage.

1531. Age of distrust: impact of hegemonic policy decisions on sexual and reproductive health and rights.

作者: Rajat Khosla.;Pascale Allotey.
来源: Lancet. 2025年405卷10481期759-761页

1532. Feeding dystonia, chorea, psychosis, and self-mutilation in an African patient with neuroacanthocytosis syndrome.

作者: Maouly Fall.;Moussa Seck.;Alassane Mamadou Diop.;Jamil Kahwagi.;Grace Tsemo Yimta.;Allé Guéye.;Pedro Rodriguez Cruz.;Mie Rizig.
来源: Lancet. 2025年

1533. A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study.

作者: John M Dennis.;Katherine G Young.;Pedro Cardoso.;Laura M Güdemann.;Andrew P McGovern.;Andrew Farmer.;Rury R Holman.;Naveed Sattar.;Trevelyan J McKinley.;Ewan R Pearson.;Angus G Jones.;Beverley M Shields.;Andrew T Hattersley.; .
来源: Lancet. 2025年405卷10480期701-714页
Data to support individualised choice of optimal glucose-lowering therapy are scarce for people with type 2 diabetes. We aimed to establish whether routinely available clinical features can be used to predict the relative glycaemic effectiveness of five glucose-lowering drug classes.

1534. 20th anniversary of the WHO Framework Convention on Tobacco Control coming into force: time for a step change in ambition.

作者: Anna B Gilmore.;Cynthia Callard.;Deborah Sy.;Blanca A Llorente.;Upendra Bhojani.;Catherine O Egbe.;Stella Aguinaga Bialous.
来源: Lancet. 2025年405卷10480期677-681页

1535. Personalised type 2 diabetes therapy in primary care.

作者: Samuel Seidu.;Deborah Ikhile.
来源: Lancet. 2025年405卷10480期672-674页

1536. Syria's health crisis transition: challenges and opportunities.

作者: Sammer Marzouk.;Alaha Nasari.;Paul B Spiegel.
来源: Lancet. 2025年405卷10483期976页

1537. A new era for HIV in the Philippines?

作者: Sharmila Devi.
来源: Lancet. 2025年405卷10479期611-612页

1538. "Silent but deadly": NCDs in sub-Saharan Africa.

作者: Jacqui Thornton.
来源: Lancet. 2025年405卷10479期609-610页

1539. Human schistosomiasis.

作者: Dora Buonfrate.;Teresa Cristina A Ferrari.;Ayola Akim Adegnika.;J Russell Stothard.;Federico G Gobbi.
来源: Lancet. 2025年405卷10479期658-670页
Schistosomiasis is a neglected tropical disease caused by infection with blood flukes of the genus Schistosoma. Widely distributed in the Middle East, southeast Asia, Latin America, and (mostly) sub-Saharan Africa, schistosomiasis is acquired upon skin penetration of infective larvae released by freshwater snails. Acute infection might present with self-limiting hypersensitivity reactions (known as Katayama fever). Chronic infection typically leads to two main clinical patterns: intestinal or urogenital schistosomiasis, depending on the infecting species. Impairment of other body sites (eg, the CNS or respiratory tract) can occur. The intestinal form is characterised by abdominal pain and diarrhoea, with or without blood; complications are hepatic fibrosis, portal hypertension, splenomegaly, and variceal bleeding. The urogenital form is characterised by dysuria and haematuria; complications are renal failure and squamous-cell carcinoma of the bladder. Conventional diagnosis is based on egg detection in faeces or urine, although sensitivity might be low. Praziquantel is the first-line treatment, and it is also provided in preventive chemotherapy campaigns by mass drug administration to afflicted communities.

1540. Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study.

作者: Michel Michaelides.;Yannik Laich.;Sui Chien Wong.;Ngozi Oluonye.;Serena Zaman.;Neruban Kumaran.;Angelos Kalitzeos.;Harry Petrushkin.;Michalis Georgiou.;Vijay Tailor.;Marc Pabst.;Kim Staeubli.;Roni O Maimon-Mor.;Peter R Jones.;Steven H Scholte.;Anastasios Georgiadis.;Jacqueline van der Spuy.;Stuart Naylor.;Alexandria Forbes.;Tessa M Dekker.;Eugene R Arulmuthu.;Alexander J Smith.;Robin R Ali.;James W B Bainbridge.
来源: Lancet. 2025年405卷10479期648-657页
Retinal dystrophy caused by genetic deficiency of AIPL1 causes severe and rapidly progressive impairment of sight from birth. We sought to evaluate whether early intervention by gene supplementation therapy was safe and could improve outcomes in children with this condition.
共有 131036 条符合本次的查询结果, 用时 3.2327393 秒